4//SEC Filing
Friedman Mark Louis 4
Accession 0000805928-21-000181
CIK 0000805928other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 4:23 PM ET
Size
9.4 KB
Accession
0000805928-21-000181
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Friedman Mark Louis
Vice President of RA/QA
Transactions
- Exercise/Conversion
Common Stock
2021-12-27+1,150→ 17,738 total - Tax Payment
Common Stock
2021-12-27$9.74/sh−286$2,786→ 17,452 total - Exercise/Conversion
Restricted Stock Units
2021-12-27−1,150→ 1,150 totalFrom: 2022-12-27Exp: 2022-12-27→ Common Stock (2,300 underlying)
Footnotes (4)
- [F1]This reflects the number of restricted stock units that vested on December 27, 2021.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of AxoGen Inc. common stock underlying the restricted stock Units will be fully vested on December 27, 2022 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on December 27, 2020 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001531023
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 4:23 PM ET
- Size
- 9.4 KB